Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
25.83
-0.09 (-0.35%)
At close: Jun 9, 2026, 4:00 PM EDT
26.21
+0.38 (1.47%)
After-hours: Jun 9, 2026, 6:52 PM EDT
Progyny Revenue
Progyny had revenue of $328.50M in the quarter ending March 31, 2026, with 1.38% growth. This brings the company's revenue in the last twelve months to $1.29B, up 6.59% year-over-year. In the year 2025, Progyny had annual revenue of $1.29B with 10.40% growth.
Revenue (ttm)
$1.29B
Revenue Growth
+6.59%
P/S Ratio
1.56
Revenue / Employee
$1,510,662
Employees
856
Market Cap
2.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.29B | 121.44M | 10.40% |
| Dec 31, 2024 | 1.17B | -121.44M | -9.42% |
| Dec 31, 2023 | 1.29B | 121.44M | 10.40% |
| Dec 31, 2022 | 1.17B | 78.62M | 7.22% |
| Dec 31, 2021 | 1.09B | 743.74M | 215.67% |
| Dec 31, 2020 | 344.86M | 115.18M | 50.15% |
| Dec 31, 2019 | 229.68M | 124.28M | 117.92% |
| Dec 31, 2018 | 105.40M | 56.82M | 116.94% |
| Dec 31, 2017 | 48.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 449.71B |
| CVS Health | 405.62B |
| The Cigna Group | 277.89B |
| Elevance Health | 200.42B |
| Centene | 178.33B |
| Humana | 137.20B |
| Molina Healthcare | 43.10B |
| Oscar Health | 13.30B |
PGNY News
- 7 days ago - Progyny price target raised to $31 from $29 at BofA - TheFly
- 12 days ago - New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System - GlobeNewsWire
- 14 days ago - Progyny announces $200M share repurchase program - TheFly
- 14 days ago - Progyny, Inc. Announces Share Repurchase Program - GlobeNewsWire
- 19 days ago - Progyny Transcript: AGM 2026 - Transcripts
- 21 days ago - Progyny upgraded to Buy from Hold at Canaccord - TheFly
- 22 days ago - Progyny price target raised to $27 from $23 at Barclays - TheFly
- 25 days ago - Progyny price target raised to $27 from $23 at Barclays - TheFly